Experts Look At How To Speed Approval Of Variant COVID-19 Vaccines

‘Global Forum’ Needed For Consensus On Requirements

Senior members of three key regulatory and health bodies this week gave their assessments of the protection that existing COVID-19 vaccines may offer against future strains of the virus, and the requirements for developing and assessing modified vaccines.

Concept image related to the concern that SARS-CoV-2 variants from UK, Brazil and South Africa might undermine available vaccines
Coronavirus variants have emerged in several countries • Source: Shutterstock

Companies seeking marketing approval of vaccines against variants of the SARS-CoV-2 virus will need to provide solid justification for the choice of variants they intend to include in their vaccines, based on a good understanding of the strains circulating at the time the variant is selected.

Regulators are discussing how new versions of existing COVID-19 vaccines can be rapidly approved, and the European Commission is close to completing a proposed legal and regulatory framework for doing...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography